TrialBritish journal of haematology2014

Wilms' Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses.

Benjamin Uttenthal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.